Biohaven Reports Second Quarter 2024 Financial Results and Recent Business DevelopmentsPRNewsWire • 08/08/24
Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx JumpInvestors Business Daily • 05/29/24
Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D DayPRNewsWire • 05/29/24
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial TumorsPRNewsWire • 05/29/24
Biohaven: Promising Pipeline With Troriluzole, Taldefgrobep Alfa, And BHV-7000 Leading The ChargeSeeking Alpha • 05/18/24
Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a TurnaroundZacks Investment Research • 05/14/24
Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a TurnaroundZacks Investment Research • 05/13/24
Biohaven Reports First Quarter 2024 Financial Results and Recent Business DevelopmentsPRNewsWire • 05/09/24
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesPRNewsWire • 04/22/24
Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business UpdatesPRNewsWire • 04/13/24
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business DevelopmentsPRNewsWire • 02/29/24
Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and OncolPRNewsWire • 01/08/24
Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual MeetingPRNewsWire • 12/01/23
Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 11/16/23
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business DevelopmentsPRNewsWire • 11/14/23